Falcipar Tablet 500mg / 25mg

About Falcipar Tablet 500mg / 25mg

Falcipar Tablet 500mg / 25mg Uses

• Treats uncomplicated malaria caused by Plasmodium falciparum
• Used as a single dose treatment under medical supervision
• Sometimes used for malaria prevention in high risk travel situations on a doctor's advice

Falcipar Tablet 500mg / 25mg Benefits

• Combination action targets parasite folate synthesis at two points
• Single dose regimen improves adherence in acute malaria treatment
• Widely available and affordable antimalarial option in Pakistan

What Experts Say

Sulfadoxine and pyrimethamine work together to block two sequential steps in the folate synthesis pathway of the malaria parasite. Sulfadoxine inhibits dihydropteroate synthase while pyrimethamine blocks dihydrofolate reductase, producing a synergistic antimalarial effect against Plasmodium falciparum.

This combination is generally reserved for chloroquine resistant strains of falciparum malaria. Physicians prescribe it as directly observed single dose therapy in most cases, which reduces the chance of poor adherence compared to multi day antimalarial regimens.

Clinicians remain cautious about severe skin reactions including Stevens Johnson syndrome linked to the sulfonamide component. Patients with sulfa allergy, glucose 6 phosphate dehydrogenase deficiency, or folate deficiency need careful evaluation before this combination is prescribed.

Drug Class

• Antifolate Antimalarial Combination

Falcipar Tablet 500mg / 25mg formula

• Sulfadoxine + Pyrimethamine

Available forms

• Tablet

How to use Falcipar Tablet 500mg / 25mg?

• Take Falcipar Tablet exactly as directed by the treating doctor, usually as a single dose
• Swallow tablets whole with water, preferably after a meal to reduce stomach upset
• Do not repeat the dose without medical advice since it is typically single dose therapy
• Complete any follow up blood tests advised by the doctor to confirm parasite clearance

Drug Interactions

• Folic Acid Antagonists: Combining with methotrexate or trimethoprim raises the risk of folate deficiency and bone marrow suppression.
• Warfarin: May increase bleeding risk by altering blood thinner metabolism.
• Other Antimalarials: Concurrent use with chloroquine or other antimalarials should only be done under medical supervision.
• Anticonvulsants: Phenytoin levels may be affected when taken together.

Risks and warnings

• Skin Reactions: Rare but serious reactions including Stevens Johnson syndrome have been linked to the sulfonamide component.
• Sulfa Allergy: Should be avoided in patients with known sulfonamide drug allergy.
• Blood Disorders: Use with caution in patients with G6PD deficiency or existing blood dyscrasias.
• Pregnancy Caution: Use only under specialist guidance, particularly in the first trimester.
• Folate Deficiency: Patients with poor nutritional folate status need close monitoring during treatment.

Falcipar Tablet 500mg / 25mg Side Effects

• Nausea and vomiting
• Loss of appetite
• Headache
• Skin rash
• Dizziness
• Mouth ulcers in rare cases
• Severe skin blistering reactions in rare cases
• Blood count changes on lab testing

Storage Conditions

• Store below 30°C in a cool, dry place
• Protect from moisture and direct sunlight
• Keep out of reach of children
• Discard any unused tablets after the treatment course as advised by the pharmacist